These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 19007888)

  • 21. Epstein-Barr virus evasion of CD8(+) and CD4(+) T cell immunity via concerted actions of multiple gene products.
    Ressing ME; Horst D; Griffin BD; Tellam J; Zuo J; Khanna R; Rowe M; Wiertz EJ
    Semin Cancer Biol; 2008 Dec; 18(6):397-408. PubMed ID: 18977445
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutual detection of Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus in blood and saliva of Cameroonians with and without Kaposi's sarcoma.
    Labo N; Marshall V; Miley W; Davis E; McCann B; Stolka KB; Ndom P; Hemingway-Foday JJ; Abassora M; Newton R; Smith JS; Whitby D
    Int J Cancer; 2019 Nov; 145(9):2468-2477. PubMed ID: 31265124
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidemiology of Epstein-Barr virus, cytomegalovirus, and Kaposi's sarcoma-associated herpesvirus infections in peripheral blood leukocytes revealed by a multiplex PCR assay.
    Nishiwaki M; Fujimuro M; Teishikata Y; Inoue H; Sasajima H; Nakaso K; Nakashima K; Sadanari H; Yamamoto T; Fujiwara Y; Ogawa N; Yokosawa H
    J Med Virol; 2006 Dec; 78(12):1635-42. PubMed ID: 17063511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [EBV/KSHV co-infection: an effective partnership].
    Gruffat H; Manet E
    Med Sci (Paris); 2018 Jan; 34(1):79-82. PubMed ID: 29384100
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Persistent KSHV Infection Increases EBV-Associated Tumor Formation In Vivo via Enhanced EBV Lytic Gene Expression.
    McHugh D; Caduff N; Barros MHM; Rämer PC; Raykova A; Murer A; Landtwing V; Quast I; Styles CT; Spohn M; Fowotade A; Delecluse HJ; Papoudou-Bai A; Lee YM; Kim JM; Middeldorp J; Schulz TF; Cesarman E; Zbinden A; Capaul R; White RE; Allday MJ; Niedobitek G; Blackbourn DJ; Grundhoff A; Münz C
    Cell Host Microbe; 2017 Jul; 22(1):61-73.e7. PubMed ID: 28704654
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The human T cell immune response to Epstein-Barr virus.
    Landais E; Saulquin X; Houssaint E
    Int J Dev Biol; 2005; 49(2-3):285-92. PubMed ID: 15906243
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of humoral immune responses to Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus using a viral proteome microarray.
    Zheng D; Wan J; Cho YG; Wang L; Chiou CJ; Pai S; Woodard C; Zhu J; Liao G; Martinez-Maza O; Qian J; Zhu H; Hayward GS; Ambinder RF; Hayward SD
    J Infect Dis; 2011 Dec; 204(11):1683-91. PubMed ID: 21990424
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD8+ T cells retain protective functions despite sustained inhibitory receptor expression during Epstein-Barr virus infection in vivo.
    Chatterjee B; Deng Y; Holler A; Nunez N; Azzi T; Vanoaica LD; Müller A; Zdimerova H; Antsiferova O; Zbinden A; Capaul R; Dreyer JH; Nadal D; Becher B; Robinson MD; Stauss H; Münz C
    PLoS Pathog; 2019 May; 15(5):e1007748. PubMed ID: 31145756
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decreased EBNA-1-specific CD8+ T cells in patients with Epstein-Barr virus-associated nasopharyngeal carcinoma.
    Fogg MH; Wirth LJ; Posner M; Wang F
    Proc Natl Acad Sci U S A; 2009 Mar; 106(9):3318-23. PubMed ID: 19211798
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Herpesvirus Epigenetic Reprogramming and Oncogenesis.
    Pei Y; Wong JH; Robertson ES
    Annu Rev Virol; 2020 Sep; 7(1):309-331. PubMed ID: 32991266
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epstein-Barr virus infection and expression in oral lesions.
    Raab-Traub N; Webster-Cyriaque J
    Oral Dis; 1997 May; 3 Suppl 1():S164-70. PubMed ID: 9456682
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epstein-Barr Virus gH/gL and Kaposi's Sarcoma-Associated Herpesvirus gH/gL Bind to Different Sites on EphA2 To Trigger Fusion.
    Chen J; Schaller S; Jardetzky TS; Longnecker R
    J Virol; 2020 Oct; 94(21):. PubMed ID: 32847853
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Conquering the Host: Determinants of Pathogenesis Learned from Murine Gammaherpesvirus 68.
    Wang Y; Tibbetts SA; Krug LT
    Annu Rev Virol; 2021 Sep; 8(1):349-371. PubMed ID: 34586873
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A new animal model for Epstein-Barr virus pathogenesis.
    Wang F
    Curr Top Microbiol Immunol; 2001; 258():201-19. PubMed ID: 11443863
    [No Abstract]   [Full Text] [Related]  

  • 35. Lytic cycle switches of oncogenic human gammaherpesviruses.
    Miller G; El-Guindy A; Countryman J; Ye J; Gradoville L
    Adv Cancer Res; 2007; 97():81-109. PubMed ID: 17419942
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human γ-Herpesvirus Infection, Tumorigenesis, and Immune Control in Mice with Reconstituted Human Immune System Components.
    Münz C
    Front Immunol; 2018; 9():238. PubMed ID: 29483919
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epstein-Barr virus microRNAs reduce immune surveillance by virus-specific CD8+ T cells.
    Albanese M; Tagawa T; Bouvet M; Maliqi L; Lutter D; Hoser J; Hastreiter M; Hayes M; Sugden B; Martin L; Moosmann A; Hammerschmidt W
    Proc Natl Acad Sci U S A; 2016 Oct; 113(42):E6467-E6475. PubMed ID: 27698133
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulatory T Cell Effect on CD8
    Lepone LM; Rappocciolo G; Piazza PA; Campbell DM; Jenkins FJ; Rinaldo CR
    AIDS Res Hum Retroviruses; 2017 Jul; 33(7):668-674. PubMed ID: 28121161
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epstein-Barr virus recombinants from BC-1 and BC-2 can immortalize human primary B lymphocytes with different levels of efficiency and in the absence of coinfection by Kaposi's sarcoma-associated herpesvirus.
    Aguirre AJ; Robertson ES
    J Virol; 2000 Jan; 74(2):735-43. PubMed ID: 10623735
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD8+ T cells far predominate over CD4+ T cells in healthy immune response to Epstein-Barr virus infected lymphoblastoid cell lines.
    Pender MP; Csurhes PA; Pfluger CM; Burrows SR
    Blood; 2012 Dec; 120(25):5085-7. PubMed ID: 23243157
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.